196 related articles for article (PubMed ID: 38574234)
1. Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates.
Montesdeoca N; Borkar RL; Sathiyendiran M; Karges J
Chemistry; 2024 Jun; 30(32):e202400217. PubMed ID: 38574234
[TBL] [Abstract][Full Text] [Related]
2. Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agents.
Pan ZY; Cai DH; He L
Dalton Trans; 2020 Aug; 49(33):11583-11590. PubMed ID: 32766642
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Accumulating Rhenium(I) Tricarbonyl Complexes Induce Cell Death via Irreversible Oxidative Stress and Glutathione Metabolism Disturbance.
Wang FX; Liang JH; Zhang H; Wang ZH; Wan Q; Tan CP; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13123-13133. PubMed ID: 30888144
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity.
He SF; Pan NL; Chen BB; Liao JX; Huang MY; Qiu HJ; Jiang DC; Wang JJ; Chen JX; Sun J
J Biol Inorg Chem; 2020 Dec; 25(8):1107-1116. PubMed ID: 33079244
[TBL] [Abstract][Full Text] [Related]
5. Highly cytotoxic Cu(II) terpyridine complexes as chemotherapeutic agents.
Ni K; Montesdeoca N; Karges J
Dalton Trans; 2024 May; 53(19):8223-8228. PubMed ID: 38652088
[TBL] [Abstract][Full Text] [Related]
6. Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
Ye RR; Tan CP; Chen MH; Hao L; Ji LN; Mao ZW
Chemistry; 2016 Jun; 22(23):7800-9. PubMed ID: 27106876
[TBL] [Abstract][Full Text] [Related]
7. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.
Ye RR; Chen BC; Lu JJ; Ma XR; Li RT
J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716
[TBL] [Abstract][Full Text] [Related]
8. Photoactivated in Vitro Anticancer Activity of Rhenium(I) Tricarbonyl Complexes Bearing Water-Soluble Phosphines.
Marker SC; MacMillan SN; Zipfel WR; Li Z; Ford PC; Wilson JJ
Inorg Chem; 2018 Feb; 57(3):1311-1331. PubMed ID: 29323880
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.
Konkankit CC; Vaughn BA; MacMillan SN; Boros E; Wilson JJ
Inorg Chem; 2019 Mar; 58(6):3895-3909. PubMed ID: 30793900
[TBL] [Abstract][Full Text] [Related]
10. Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy.
Liew HS; Mai CW; Zulkefeli M; Madheswaran T; Kiew LV; Delsuc N; Low ML
Molecules; 2020 Sep; 25(18):. PubMed ID: 32932573
[TBL] [Abstract][Full Text] [Related]
11. Systematically altering the lipophilicity of rhenium(I) tricarbonyl anticancer agents to tune the rate at which they induce cell death.
Konkankit CC; Vaughn BA; Huang Z; Boros E; Wilson JJ
Dalton Trans; 2020 Nov; 49(45):16062-16066. PubMed ID: 32319485
[TBL] [Abstract][Full Text] [Related]
12. Neutral rhenium(I) tricarbonyl complexes with sulfur-donor ligands: anti-proliferative activity and cellular localization.
Levina A; Wardhani K; Stephens LJ; Werrett MV; Caporale C; Dallerba E; Blair VL; Massi M; Lay PA; Andrews PC
Dalton Trans; 2024 May; 53(18):7866-7879. PubMed ID: 38632950
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity, cellular localization and photophysical properties of Re(I) tricarbonyl complexes bound to cysteine and its derivatives.
Capper MS; Enriquez Garcia A; Macia N; Lai B; Lin JB; Nomura M; Alihosseinzadeh A; Ponnurangam S; Heyne B; Shemanko CS; Jalilehvand F
J Biol Inorg Chem; 2020 Aug; 25(5):759-776. PubMed ID: 32583226
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
15. Rhenium-Based Complexes and in Vivo Testing: A Brief History.
Capper MS; Packman H; Rehkämper M
Chembiochem; 2020 Aug; 21(15):2111-2115. PubMed ID: 32196894
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
Knopf KM; Murphy BL; MacMillan SN; Baskin JM; Barr MP; Boros E; Wilson JJ
J Am Chem Soc; 2017 Oct; 139(40):14302-14314. PubMed ID: 28948792
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
18. Osmium(VI) nitride triggers mitochondria-induced oncosis and apoptosis.
Ye M; Huang WQ; Li ZX; Wang CX; Liu T; Chen Y; Hor CH; Man WL; Ni WX
Chem Commun (Camb); 2022 Feb; 58(15):2468-2471. PubMed ID: 35024704
[TBL] [Abstract][Full Text] [Related]
19. Exploring Ovarian Cancer Cell Resistance to Rhenium Anticancer Complexes.
Marker SC; King AP; Swanda RV; Vaughn B; Boros E; Qian SB; Wilson JJ
Angew Chem Int Ed Engl; 2020 Aug; 59(32):13391-13400. PubMed ID: 32396709
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes.
Wen Y; Ouyang C; Li Q; Rees TW; Qiu K; Ji L; Chao H
Dalton Trans; 2020 Jun; 49(21):7044-7052. PubMed ID: 32406463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
